These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

220 related articles for article (PubMed ID: 37905690)

  • 1. Novel molecular mechanism driving neuroprotection after soluble epoxide hydrolase inhibition: Insights for Alzheimer's disease therapeutics.
    Griñán-Ferré C; Jarné-Ferrer J; Bellver-Sanchís A; Codony S; Puigoriol-Illamola D; Sanfeliu C; Oh Y; Lee S; Vázquez S; Pallàs M
    CNS Neurosci Ther; 2024 Apr; 30(4):e14511. PubMed ID: 37905690
    [TBL] [Abstract][Full Text] [Related]  

  • 2. 1-Trifluoromethoxyphenyl-3-(1-propionylpiperidin-4-yl) Urea, a Selective and Potent Dual Inhibitor of Soluble Epoxide Hydrolase and p38 Kinase Intervenes in Alzheimer's Signaling in Human Nerve Cells.
    Liang Z; Zhang B; Xu M; Morisseau C; Hwang SH; Hammock BD; Li QX
    ACS Chem Neurosci; 2019 Sep; 10(9):4018-4030. PubMed ID: 31378059
    [TBL] [Abstract][Full Text] [Related]  

  • 3. 14,15-Epoxyeicosatrienoic Acid Alleviates Pathology in a Mouse Model of Alzheimer's Disease.
    Chen W; Wang M; Zhu M; Xiong W; Qin X; Zhu X
    J Neurosci; 2020 Oct; 40(42):8188-8203. PubMed ID: 32973044
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pharmacological Inhibition of Soluble Epoxide Hydrolase as a New Therapy for Alzheimer's Disease.
    Griñán-Ferré C; Codony S; Pujol E; Yang J; Leiva R; Escolano C; Puigoriol-Illamola D; Companys-Alemany J; Corpas R; Sanfeliu C; Pérez B; Loza MI; Brea J; Morisseau C; Hammock BD; Vázquez S; Pallàs M; Galdeano C
    Neurotherapeutics; 2020 Oct; 17(4):1825-1835. PubMed ID: 32488482
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Genetic deletion of soluble epoxide hydrolase delays the progression of Alzheimer's disease.
    Lee HT; Lee KI; Chen CH; Lee TS
    J Neuroinflammation; 2019 Dec; 16(1):267. PubMed ID: 31847859
    [TBL] [Abstract][Full Text] [Related]  

  • 6. EETs/sEHi alleviates nociception by blocking the crosslink between endoplasmic reticulum stress and neuroinflammation in a central poststroke pain model.
    Liu T; Li T; Chen X; Li Z; Feng M; Yao W; Wan L; Zhang C; Zhang Y
    J Neuroinflammation; 2021 Sep; 18(1):211. PubMed ID: 34530836
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Neuroprotective Epigenetic Changes Induced by Maternal Treatment with an Inhibitor of Soluble Epoxide Hydrolase Prevents Early Alzheimer's Disease Neurodegeneration.
    Bartra C; Irisarri A; Villoslada A; Corpas R; Aguirre S; García-Lara E; Suñol C; Pallàs M; Griñán-Ferré C; Sanfeliu C
    Int J Mol Sci; 2022 Dec; 23(23):. PubMed ID: 36499477
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Soluble epoxide hydrolase modulates immune responses in activated astrocytes involving regulation of STAT3 activity.
    Hung CC; Lee YH; Kuo YM; Hsu PC; Tsay HJ; Hsu YT; Lee CC; Liang JJ; Shie FS
    J Neuroinflammation; 2019 Jun; 16(1):123. PubMed ID: 31176371
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The neuroprotective N-terminal amyloid-β core hexapeptide reverses reactive gliosis and gliotoxicity in Alzheimer's disease pathology models.
    Lantz MJ; Roberts AM; Delgado DD; Nichols RA
    J Neuroinflammation; 2023 May; 20(1):129. PubMed ID: 37245024
    [TBL] [Abstract][Full Text] [Related]  

  • 10. SLOH, a carbazole-based fluorophore, mitigates neuropathology and behavioral impairment in the triple-transgenic mouse model of Alzheimer's disease.
    Wu X; Kosaraju J; Zhou W; Tam KY
    Neuropharmacology; 2018 Mar; 131():351-363. PubMed ID: 29309769
    [TBL] [Abstract][Full Text] [Related]  

  • 11. MT5-MMP promotes neuroinflammation, neuronal excitability and Aβ production in primary neuron/astrocyte cultures from the 5xFAD mouse model of Alzheimer's disease.
    Pilat D; Paumier JM; García-González L; Louis L; Stephan D; Manrique C; Khrestchatisky M; Di Pasquale E; Baranger K; Rivera S
    J Neuroinflammation; 2022 Mar; 19(1):65. PubMed ID: 35277173
    [TBL] [Abstract][Full Text] [Related]  

  • 12. An epoxide hydrolase inhibitor reduces neuroinflammation in a mouse model of Alzheimer's disease.
    Ghosh A; Comerota MM; Wan D; Chen F; Propson NE; Hwang SH; Hammock BD; Zheng H
    Sci Transl Med; 2020 Dec; 12(573):. PubMed ID: 33298560
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Activation of the nuclear receptor PPARδ is neuroprotective in a transgenic mouse model of Alzheimer's disease through inhibition of inflammation.
    Malm T; Mariani M; Donovan LJ; Neilson L; Landreth GE
    J Neuroinflammation; 2015 Jan; 12():7. PubMed ID: 25592770
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Ex vivo expanded human regulatory T cells modify neuroinflammation in a preclinical model of Alzheimer's disease.
    Faridar A; Vasquez M; Thome AD; Yin Z; Xuan H; Wang JH; Wen S; Li X; Thonhoff JR; Zhao W; Zhao H; Beers DR; Wong STC; Masdeu JC; Appel SH
    Acta Neuropathol Commun; 2022 Sep; 10(1):144. PubMed ID: 36180898
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Soluble Epoxide Hydrolase Inhibition Attenuates Excitotoxicity Involving 14,15-Epoxyeicosatrienoic Acid-Mediated Astrocytic Survival and Plasticity to Preserve Glutamate Homeostasis.
    Kuo YM; Hsu PC; Hung CC; Hu YY; Huang YJ; Gan YL; Lin CH; Shie FS; Chang WK; Kao LS; Tsou MY; Lee YH
    Mol Neurobiol; 2019 Dec; 56(12):8451-8474. PubMed ID: 31257558
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Genetic deletion or pharmacological inhibition of soluble epoxide hydrolase reduces brain damage and attenuates neuroinflammation after intracerebral hemorrhage.
    Wu CH; Shyue SK; Hung TH; Wen S; Lin CC; Chang CF; Chen SF
    J Neuroinflammation; 2017 Nov; 14(1):230. PubMed ID: 29178914
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Inhibition of sEH via stabilizing the level of EETs alleviated Alzheimer's disease through GSK3β signaling pathway.
    Sun CP; Zhang XY; Zhou JJ; Huo XK; Yu ZL; Morisseau C; Hammock BD; Ma XC
    Food Chem Toxicol; 2021 Oct; 156():112516. PubMed ID: 34411643
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Soluble epoxide hydrolase inhibitor attenuates inflammation and airway hyperresponsiveness in mice.
    Yang J; Bratt J; Franzi L; Liu JY; Zhang G; Zeki AA; Vogel CF; Williams K; Dong H; Lin Y; Hwang SH; Kenyon NJ; Hammock BD
    Am J Respir Cell Mol Biol; 2015 Jan; 52(1):46-55. PubMed ID: 24922186
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Modulation of neuroinflammation and pathology in the 5XFAD mouse model of Alzheimer's disease using a biased and selective beta-1 adrenergic receptor partial agonist.
    Ardestani PM; Evans AK; Yi B; Nguyen T; Coutellier L; Shamloo M
    Neuropharmacology; 2017 Apr; 116():371-386. PubMed ID: 28089846
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Protective effects of CCL01 against Aβ-induced neurotoxicity in 5xFAD transgenic mouse model of Alzheimer's disease.
    Ju IG; Son SY; Lee S; Im H; Huh E; Eo H; Choi JG; Sohn MW; Yim SV; Kim SY; Kim DH; Lee CH; Oh MS
    Biomed Pharmacother; 2023 Feb; 158():114105. PubMed ID: 36508997
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.